Source: http://the-gadgeteer.com/2011/12/23/use-the-power-of-your-mind-with-the-mindflex-duel-game/
matt cassel snowman google music willis mcgahee willis mcgahee 2013 ford escape stop online piracy act
Source: http://the-gadgeteer.com/2011/12/23/use-the-power-of-your-mind-with-the-mindflex-duel-game/
matt cassel snowman google music willis mcgahee willis mcgahee 2013 ford escape stop online piracy act
Seeka Kiwifruit Industries, the grower which attempted to merge with rival Satara Cooperative this year, said it won?t pay a final dividend as it focuses on repaying debt.
The listed fruit grower and packer expects full year earnings before interest, tax, depreciation, amortisation, fair value adjustments and asset revaluations to be in the range of $20 million to $21 million, from $19.8 million in the nine months ended Dec. 31.
The company said it will focus on reduction in bank debt and as part of that strategy it won?t pay a December dividend. No dividends were declared at the end of the 2010 financial year either.
In November, 48 percent of shareholders in rival Satara voted against a proposed merger, which was seen as giving scale in an industry hurt by the vine-wasting disease PSA-V. The vote fell short of the 75 percent majority needed.
Satara advised the NZX in a statement it holds no assets for sale and has no intention to sell any assets at this point in time. It made the statement in response to what it said were issues raised at its recent shareholder meeting this month.
At the meeting shareholders were told directors are working to generate sufficient profits to reward all shareholders, sustain rebates, pay a dividend and have enough money left to re-invest in the business.
Shares in Satara have halved in value in the past five years to trade recently at 38 cents, while Seeka share are currently trading at 90 cents.
BusinessDesk.co.nz
No comments yet
UPDATE: Seeka flags lower profit on Psa but will comply with bank covenants
Seeka flags lower profit on Psa but will comply with bank covenants
Seeka appoints new Director
Italian kiwifruit orchard write-off won't impact Seeka earnings
Seeka 1st-half profit edges lower after Vital Foods write-down; outlook brighter
Seeka writes off investment in Vital Foods, shares jump 13%
Seeka Kiwifruit Industries Limited Ordinary Shares
Current quote:
SEK $0.90
Quotes delayed 20 minutes
Price when article published: $0.90
Previous News
FREE Email News
Stock Quote
Today's Market Numbers
Most Commented On
NZX 15 Index
c.j. wilson three stooges pujols mythbusters miami marlins hanley ramirez blago
Mortgage rates fall to new low for the year, but loan volume for home buyers and refinancers also drops. Historically low mortgage rates are not enough to boost demand, says Mortgage Bankers Association.
Maybe it's the holiday season. Or fear about the economy. Or expectations that rates will go even lower next year.
Skip to next paragraphWhatever it is, Americans are not taking advantage of historic low mortgage rates.
Even though rates fell to a new low for the year, fewer Americans applied for mortgages to buy homes or refinanced their existing mortgages last week, according to the Mortgage Bankers Association (MBA).?The group's composite index of loan volume fell 2.6 percent on a seasonally adjusted basis (2.8 percent on a seasonally adjusted basis). The decline in home buyers was even steeper 4.9 percent, while the refinancing index dropped 1.6 percent.
"Remarkably low rates are not enough, as many homeowners continue to hold back due to lack of equity in their properties, poor credit, and a weak job market," Michael Fratantoni, MBA's vice president of research and economics, said in a statement.
The average rates for a 30-year fixed mortgage dropped to 4.08 percent, the lowest rate of 2011, MBA reported, with 0.49 points. The average for a 15-year fixed mortgage was 3.39 percent with 0.40 points, also a new low for the year.
Will rates fall even lower next year? With turmoil in the eurozone causing investors to seek safety in US Treasury bonds (which lowers interest rates), some analysts see rates dipping a bit more in coming months.
Even if they don't reach new lows, current levels are at levels not seen since at least the 1950s. And they'll remain extremely attractive through 2012, forecasts Greg McBride, senior financial analyst for Bankrate.com, an online aggregator of financial rate information.
Source: http://rss.csmonitor.com/~r/feeds/csm/~3/0OlHVV1k_Gk/Mortgage-rates-at-record-lows.-Home-buyers-yawn
ginger white conrad murray sentencing conrad murray sentencing urban meyer adam shulman adam shulman nfl power rankings week 13
Just when you thought the U.S. was safe from amoebas . . . it turns out it?s not.
This summer saw a micro-burst of brain-eating amoeba attacks (well, only three, but that was plenty for the press to get its panties in a bunch over it. How could you not about ?brain-eating amoebas??) in people who swam in U.S. freshwater lakes, ponds, etc. You?d think the commencement of North American winter would preclude further possibility of attack. Alas, it does not. For this is the ?amoeba?s? new secret weapon: the neti pot.
The notorious neti pot. Creative Commons image by Kurt Yoder, 2004. Click image for license and link.
Yes, the Neti pot. For those of you unfamiliar with this contraption, the idea is that instead of honking your way to kingdom come into a scratchy paper tissue, you can gracefully irrigate your way to an obstruction-free breathing by pouring the contents of a Neti pot into one nostril and out the other. Exhibit A:
A neti pot in action. Creative Commons image by Aikhan. Click for license and link.
Although I?ve never tried this, I?d say it?s probably easier said than done, at least to start. But it does seem to be effective, once mastered, based on what I?ve read.
Unless, that is, the tap water you use to fill the pot is home to some wayward ?amoebas? called Naegleria fowleri. Somehow they can slip through the microbial Fort Knox of some U.S. water treatment plants and make it into tap water (at least in Louisiana).
This is not a problem if you drink the water and they end up in your stomach, where they are digested. This is very much is a problem if you dribble them through your sinus system, where they seem to occasionally find their way brainward with the same efficacy they display in unlucky swimmers who accidentally inhale some protist-infested pond water while swimming. Once they wander into your brain, death is almost certain.
There?s an easy solution, though. Just boil your neti pot water first, or use store-bought distilled water. And in any event, only two people in Louisiana have died from infested neti pots this year. So don?t panic. This rates nowhere near the level of concern that should be inspired by, say, getting in your car and driving it down the street. These amoebas don?t seek out humans. They just go sightseeing when they happen to be in the neighborhood. Unfortunately, the sight they?re seeing is your gray matter.
For those of you who missed it and are curious exactly what Naegleria fowleri is (it?s not actually a true amoeba), I?m reprinting my post from August on this very subject below:
Cyst, trophozoite ("amoeba"), and flagellate forms of the protist Naegleria fowleri. Photos by CDC.
In the press this week were reports (see here and here and here) that the brain-eating amoeba Naegleria fowleri has killed three people this summer, as it does in a typical year. The only trouble is, Naegleria isn?t a true amoeba.
So why are they called amoebas if they are not? The organisms in question ? which, like true amoebas are microbes called protists ? do alternate between cysts, flagellate (swimming) forms, and amoeba-like (blobby, crawling) forms that are more properly called ?trophozoites?. When times are good, these trophozoites crawl through the mud in search of bacteria to eat. When times are bad, they sprout tails and swim off like guided missiles in search of happier hunting grounds. Either of these forms can rarely, accidentally infect humans, typically in warm, shallow water in the southern U.S. in summertime. When times get *really* bad, they encyst. Click here for a CDC graphic of their life cycle (on the left). But the trophozoite forms only superficially resemble amoebas; their DNA tells us they are something much different indeed.
Naegleria, it turns out, is only a distant relative of the Amoebozoa, the true amoebae, which generally lack flagella. In fact, the true amoebae seem to be more closely related to fungi and animals than it they are to Heterolobosea, the phylum that includes Naegleria. Naegleria, in turn, seem to be much more closely related to Euglena ? the flagellated (tailed) photosynthetic single-celled organisms from high school and college biology lab ? and Trypanosoma, the causal organisms of sleeping sickness and Chagas disease. Take a look at this family tree of eukaryotes (nucleated organisms ? everything except bacteria and archaea) for the groups Amoebozoa and Heterolobosea to see what I mean.
Heterolobosea are difficult to define in a sentence, since they have evolved into so many niches. What tells us they are related is their DNA. But generally speaking, the phylum that includes Naegleria is made up of organisms that alternate between amoeboid and swimming forms, and that, like the Euglenozoa, have ?discoid? cristae, or folds, in their energy-producing mitochondria. In contrast, most animals, I believe, have sheet-like or laminar cristae. How exactly discoid is different from laminar I have not been able to discover. For extra randomness, the Heterolobosea also includes a group of slime molds that?s completely unrelated to the big showy ones most people (if they ever think of them) think of as slime molds.
The proposed kingdom to which the Heterolobosea belong ? the Excavata ? are even more of a mixed bag, although again one might say they are almost exclusively protists with either no or unusual mitochondria, two or more flagella for swimming, and a characteristic underside feeding groove supported by fibers called microtubules.
There are true amoebas that infect humans. Entamoeba histolytica comes to mind, the cause of the vastly more prevalent disease amoebic dysentary, which infects some 50 million worldwide. Naegleria, on the other hand, are not parasites of humans; they prefer bacteria and don?t seek out people. They only infect us when we swim into their habitat and happen to bump into them nose-first. Hungry and far from home, they crawl into our brains and start eating like crazy, killing the unfortunate host 95% of the time.
But as a result of its accidental nature, Naeglaria infection is quite rare in the United States ? happening perhaps 2-3 times a year ? especially compared to organisms that do seek us out in water. As a blog post at the L.A. Times points out:
According to the Centers for Disease Control and Prevention, the most commonly reported recreational water illness (RWI) is diarrhea, which can be caused by germs such as Cryptosporidium, Giardia, Shigella, norovirus and E. coli. These can be introduced into the water through trace amounts of fecal matter that cling to people?s bodies. The agency reports:
Swimmers share the water ? and the germs in it ? with every person who enters the pool. On average, people have about 0.14 grams of feces on their bottoms which, when rinsed off, can contaminate recreational water. In addition, when someone is ill with diarrhea, their stool can contain millions of germs. This means that just one person with diarrhea can easily contaminate the water in a large pool or water park.
I think I could have gone my whole life without knowing each and every bottom in the pool contains 0.14 grams of feces. It certainly makes a hard sell for the bidet. This fact alone should be *much* more frightening than the chance that a little, lost, hungry protist might somehow find its way into your brain, no matter how food-crazed it might be once it gets there. And if you?re still worried, there?s always nose clips.
Source: http://rss.sciam.com/click.phdo?i=4f488ac7462fffe95219f51bd51fb00c
role models big ten championship game big ten championship game ultimate fighter 14 ultimate fighter 14 2011 bowl projections michigan state
WASHINGTON?? Dr. Ned Calonge knows firsthand how hard it is to tell Americans they'd be better off with fewer routine medical tests.
Don't miss these Health stories
Study finds that babies can tell whether adults are reliable or not.
A long-time family doctor in Colorado, Calonge presided over the U.S. Preventive Services Task Force, an influential government-backed panel of health experts, when it said that most women under 50 could skip their regular mammograms.
The recommendation two years ago challenged the conviction of many breast cancer patients that they survived precisely because they were screened early. It unleashed a public fury that has weighed on the panel's deliberations ever since.
"We blew the message," said Calonge, now president and CEO of the Colorado Trust foundation. "The nuance was completely gone."
Two men phoned in death threats to Calonge. Protesters showed up by the offices of the government agency that supports the panel, tucked away in a Maryland suburb. The furor slowed down work on a decision to limit prostate cancer screenings as President Barack Obama fought to pass his signature healthcare law and his Democratic party faced a mid-term election challenge in 2010.
"There was a lot of pressure from above to be more careful politically and orchestrate things better," said Dr. Kenneth Lin, who at the time was an officer at the Agency for Healthcare Research and Quality (AHRQ), a Department of Health and Human Services entity that supports the panel. "Everything with the word 'cancer' got shoved back."
Calonge rotated off the panel this past March after eight years, while Lin quit AHRQ late last year in protest over the delay to prostate cancer screening guidelines that were only released in October. A White House official noted that Calonge has attributed the delay in a final decision on prostate cancer screenings to scheduling conflicts.
Their experience shows just how difficult it will be to curb spiraling costs in the world's most expensive healthcare system by determining what screenings work, based on a rigorous study of clinical evidence, and what can lead to unnecessary and risky procedures.
"More screening is not always better," said Dr. Christine Laine, a general internist and editor of the Annals of Internal Medicine who is not part of the panel. "That message is lost in healthcare in general."
The U.S. Preventive Services Task Force is right on the firing line. For much of its 27-year history, it helped convince millions of Americans to get screened early for disease.
Now the panel of primary care doctors, nurses and academics has reviewed a growing body of research that shows some early screening harms more people than it helps. But it has struggled to convince patients and doctors.
In the wake of the mammogram guidelines, the rate of such screenings for women aged 40 to 69 was barely changed in 2010 compared with 2009, according to the National Committee for Quality Assurance.
"We have a public health measure that we know is effective. Why is it continually being questioned?" said Dr. Carol Lee, breast imaging commission chairwoman at the American College of Radiology.
Broaching the negatives
The public at large is no less skeptical. A recent Gallup poll showed that nearly 60 percent of Americans believed that standard cancer screenings ? including mammograms and prostate specific antigen (PSA) blood tests ? were performed often enough. Thirty-one percent thought they should be conducted more frequently. Only 7 percent said they were done too often.
"It's extraordinarily hard to give up the notion that there's a way to protect yourself from dying from cancer... Our goal here is to make it a matter of evidence, not a matter of opinion," said Virginia Moyer, a pediatrician from Baylor College of Medicine, who now chairs the 16-member panel.
"Our successes are measured in positives," she said of the public's growing awareness of screening in the last three decades. "We are just beginning to approach the negatives."
Burned by the experience with mammograms, the task force is looking for a better way to deliver the message, consulting with powerful consumer interest groups, hiring public relations professionals and reworking some of the language tied to its system of letter-based recommendations.
"We're spending more time paying attention to how we say things to make sure it's understood well," said long-time panel member and current co-vice chair Dr. Michael LeFevre, a professor of family medicine at the University of Missouri School of Medicine. "We have no interest in being some wizard behind the curtain."
The panel now issues its recommendations in draft form first and solicits public comment before making them final. In about a year, the public may have a chance to chime in early on the evaluation process, including posing questions for researchers and reviewing the evidence report draft used by the panel.
Task force officials concede that the comments are unlikely to change the recommended letter grade, unless they introduce crucial new evidence. But they can point to misunderstandings and help the panel better craft its message.
In late October, the panel met with consumer interest groups, including retired persons lobby AARP and the Consumers Union, to get input on how to frame recommendations that was once reserved for patient advocates.
The public's participation has been unprecedented. The panel is now finalizing its PSA prostate cancer recommendation and public comments on the subject have reached into the thousands, LeFevre said.
Weighing the evidence
The 2009 mammogram guidance from the task force was based on the panel's assessment of new research that showed most women over 40 face a 3 percent risk of dying from breast cancer if they have not been screened. Beginning mammogram screening at age 50 and following up every other year reduced that risk to 2.3 percent, compared with 2.2 percent risk starting at age 40.
An extra decade of screening could invite harms such as unnecessary biopsies and tests, the possible treatment of non-deadly cancers and radiation. Women in their forties are also more likely to receive false positive results.
Another view of the data showed that starting screening at age 40 led to 5,000 more mammograms, 500 false positive results and 33 biopsies for every breast cancer death prevented, according to LeFevre.
"If it was just how many deaths do you cause versus how many deaths you prevent, that would be too easy, that would be simple math," LeFevre said. "We start with somebody who feels well, and we risk making them feel worse."
The panel voted on a "C" recommendation, which calls for patients to decide on the screening with their doctor. But when the recommendation came out in November 2009, it started with a sentence saying the panel "recommends against" routine mammograms for most women under 50, and that language triggered the controversy.
Under pressure, the task force dropped the phrase "recommends against" a month later. Its rating on mammograms remains a "C."
The American Cancer Society questioned the evidence, saying the panel focused on gold-standard clinical trials but weeded out newer observational studies that showed better results.
"Screening is not perfect and it's not error-free, but the question is... do you take protective measures against the unlikely probability that you develop cancer... or do you take your chances?" said Robert Smith, director of cancer screening at the ACS.
That calculation still appears to be guiding doctors, either out of concern of missing an early sign of disease or fear of lawsuits, health experts said.
"Shared decision-making (between doctors and patients) sounds nice, but in practice usually you just end up
Copyright 2011 Thomson Reuters. Click for restrictions.
Source: http://www.msnbc.msn.com/id/45715552/ns/health-cancer/
justin verlander pepper spraying cop pepper spraying cop somaya reece college board padma lakshmi juelz santana
As his production company is behind TV Land's "Hot in Cleveland," Sean Hayes has gotten to know Betty White very well. He even has a guest spot coming up in the third season of the hit show. He admitted that he's amazing by her energy at nearly 90 years old on "The Late Late Show" (Weeknights, 12:30AM ET on CBS).
"She's actually 112," Craig Ferguson quipped. "Lithe for her age."
The pair shifted gears a bit when Ferguson asked Hayes if he knew Oprah Winfrey. Without missing a beat, Hayes responded, "She actually drove me today." He even said she was outside the studio waiting for him with Stedman.
It was certainly gracious of her to take the time out of her schedule so shortly after her trip to Haiti, where she toured an encampment for Haitians displaced by the massive 2010 earthquake.
TV Replay scours the vast television landscape to find the most interesting, amusing, and, on a good day, amazing moments, and delivers them right to your browser.
'; var coords = [-5, -72]; // display fb-bubble FloatingPrompt.embed(this, html, undefined, 'top', {fp_intersects:1, timeout_remove:2000,ignore_arrow: true, width:236, add_xy:coords, class_name: 'clear-overlay'}); });donovan mcnabb the waltons the waltons weta weta rudolph the red nosed reindeer rudolph the red nosed reindeer
HOUSTON ? Luis Scola scored 20 points, Terrence Williams had 14 and the Houston Rockets beat the short-handed San Antonio Spurs 101-87 on Saturday night.
Jordan Hill had 17 points and 13 rebounds for the Rockets, who had a 56-38 edge on the boards. Williams also had nine rebounds.
Manu Ginobili and DeJuan Blair scored 16 points apiece for the Spurs. Tim Duncan and Tony Parker sat out for San Antonio.
Houston led 51-36 at halftime after the Spurs went 8 for 40 from the field in the half. Ginobili went 2 for 10 in the first half.
The Rockets pushed the margin over 20 in the third quarter. The Spurs rallied, but a Houston lineup of reserves led by Williams held on for the victory.
graham spanier penn state board of trustees joe pa joe pa brett ratner jerry sandusky toyota recall